
LCTX Market Capitalization Overview
Market Cap: $377.74M as of Jan 2, 2026
$377.74M
$6.91M (1.86%)past month
As of Jan 2, 2026, LCTX has a market capitalization of $377.74M. Over the past 30 days, its market cap has decreased by -1.2%, while in the last 12 months, it has decreased by -1.8%.
Market capitalization represents the total value of Lineage Cell Therapeutics Inc as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
LCTX Market Cap Formula = Stock Price * Shares Outstanding
The market cap of LCTX helps investors assess the company's size and compare it with competitors for better investment decisions.
Market capitalization represents the total value of Lineage Cell Therapeutics Inc as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
LCTX Market Cap Formula = Stock Price * Shares Outstanding
The market cap of LCTX helps investors assess the company's size and compare it with competitors for better investment decisions.
LCTX Market Cap & Key Trends
See Lineage Cell Therapeutics Inc’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.
Start investing in LCTX
Order type
Buy in
Order amount
Est. shares
0 shares
LCTX Market Cap History
| Date | Market Cap | Change |
|---|---|---|
| Dec 1, 2025 | $382.35M | -14.57% |
| Nov 3, 2025 | $447.58M | +15.98% |
| Oct 1, 2025 | $385.93M | +38.52% |
| Sep 2, 2025 | $278.60M | +23.82% |
| Aug 1, 2025 | $224.99M | +9.76% |
| Jul 1, 2025 | $204.99M | +34.99% |
| Jun 2, 2025 | $151.86M | +31.94% |
| May 1, 2025 | $115.10M | +22.63% |
| Apr 1, 2025 | $93.86M | -16.53% |
| Mar 3, 2025 | $112.44M | -26.02% |
| Feb 3, 2025 | $151.98M | +33.88% |
| Jan 2, 2025 | $113.52M | +2.13% |
LCTX End of Year Market Cap History
| Date | Market Cap | Change |
|---|---|---|
| 2026 | $377.74M | -1.80% |
| 2025 | $384.65M | +247.28% |
| 2024 | $110.76M | -41.93% |
| 2023 | $190.74M | -4.09% |
| 2022 | $198.88M | -51.84% |
| 2021 | $412.97M | — |
FAQs About Lineage Cell Therapeutics Inc (LCTX) Market Cap
As of Jan 2, 2026, the market capitalization of LCTX is $377.74M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.
In the last 30 days, Lineage Cell Therapeutics Inc’s market capitalization has increased by 1.86%, changing from $370.83M to $377.74M as of Jan 2, 2026.
In the last 3 months, Lineage Cell Therapeutics Inc’s market capitalization has increased by —, changing from – to – as of –.
In the year 2025, Lineage Cell Therapeutics Inc’s market capitalization increased from $110.76M in January to $384.65M in December, reflecting a 247.28% change.
In the past five years, LCTX has had a compound annual growth rate (CAGR) of -1.41% in market capitalization. This means its market cap has shrunk at an average rate of -1.41% per year.